Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide.

Alon, Danny; Paitan, Yossi; Robinson, Eyal; Ganor, Nirit; Lipovetsky, Julia; Yerushalmi, Rinat; Cohen, Cyrille J; Raiter, Annat.

Afiliação

Alon D; Department of Medicine A, Meir Medical Center, Kfar Saba, Israel.
Paitan Y; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Robinson E; Microbiology Laboratory, Meir Medical Center, Kfar Saba, Israel.
Ganor N; Department of Medicine B, Meir Medical Center, Kfar Saba, Israel.
Lipovetsky J; Microbiology Laboratory, Meir Medical Center, Kfar Saba, Israel.
Yerushalmi R; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Cohen CJ; Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, Israel.
Raiter A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Front Med (Lausanne) ; 8: 675963, 2021.

Article em En | MEDLINE | ID: mdl-34414199